Lex Talionis

Analyst & Investor | Angel & Punisher

[RADFORSK @radforsk]

Vårt porteføljeselskap #PCIBIOTECH er nå på hovedlisten til @osloboers. Stor dag for Per Walday og kollegaene. Gratulerer så mye! Foto: Thomas Brun/ NTB Scanpix.

[ASH @ASH_hematology]

Pilot trial of ibrutinib in patients with relapsed or refractory T-cell #lymphoma https://t.co/39UoQoBbQi via @BloodAdvances #lymsm

[Infront @infrontfinance]

Do you want to stay ahead of the report season? Use the (old but gold) calendar function in the terminal to receive reminders and see expected results: https://t.co/o6zDjSd4BI Make sure you have the right access to result and corporate actions via: @Borsredaktion & @FactSet //

[Karl O. Strøm @KarlOStrom]

Varslene strøymer på for oppgang i US rente. @infrontfinance raskest, fulgt av @e24 3 min senere. Gode, gamle Wall Street Journal må skjerpe seg. 😉

[Magnus Vie Sundal @MagnusVieSundal]

US 10y government bond yield briefly (for 1 minute) breaks through 3%
#US #Economy #Interest #Rate

[zerohedge @zerohedge]

Ranked: The Best And Worst State Economies https://t.co/B1IC09jBkH

[CNBC @CNBC]

"Yes, it's entirely possible that stock market multiples and maybe venture capital multiples have peaked for the cycle... maybe the silver lining is, we're not going to blow a bubble of massive proportions." @ReformedBroker on rising rates at @SohnConf. #Sohn2018

[HealthCap @HealthCapVC]

MIPS receives a positive decision in European patent case https://t.co/4rbd5Xv03Z

[Labiotech.eu @Labiotech_eu]

Looking good @BGenBio! #checkpointinhibiotrs are rocking the show 😎 #cancer #enzyme #biotech https://t.co/GWwsiTjsL6

[Dagens Medisin @DagensMedisin]

@Kreftforeningen sin hederspris går til multikunstner Jan @JanVincents https://t.co/S4ePKSVzd8

[Elon Musk @elonmusk]

@TheEconomist The Economist used to be boring, but smart with a wicked dry wit. Now it’s just boring (sigh). Tesla will be profitable & cash flow+ in Q3 & Q4, so obv no need to raise money.

[Lars Mørland Knudsen @larsmkn]

Her er det bare å hive seg på @BGenBio ! Super Podcast! Ville tipset Nordic Nanovector også, men de har jo ikke twitterprofil... #GetWithTheTimes $BGBIO $NANO https://t.co/qfX9mzVxZA

[RADFORSK @radforsk]

Ny episode av podkasten Radium er ute nå: Dette er en lytterspesial hvor vi svarer på spørsmål vi har fått inn. Det ble mye om Nordic Nanovector, men vi snakker også om PCI Biotech, @targovax og annet: https://t.co/mHut9ak5kC

[RADFORSK @radforsk]

– Vi skreddersyr kreftvaksiner til hver pasient. Vi tar immunterapi ett skritt videre, og bruker kunnskapen til å utvikle enda mer persontilpasset medisin, sier president og grunnlegger av #Vaccibody, @ABFredriksen, til VG. https://t.co/MpUzjY15Qa

[Jacob Plieth @JacobPlieth]

Main takeaway from $ALXN call was plan to modify Wilson's phase III design, prob to show superiority vs $VRX Cuprimine & Spyrine

[Agnete B. Fredriksen @ABFredriksen]

First patient on board-now the future starts in Vaccibody! Creating one unique cancer vaccine per patient. https://t.co/vQoEBKaAVI

[Sigmund Berg @freud_fjell]

Jeg har skrevet blogginnlegg om immunterapi, der jeg blant annet forteller om forskningen til @pkselbo fra @radforsk #vitensnakk https://t.co/Kz6uGgS8rK

[Bertrand Delsuc @BertrandBio]

⚡️ “Euronext biotechs 2018 pipeline & milestones” by @BiotechRadar - compilation regularly updated of 50 🇪🇺bios incl. $GLPG $ABLX $ARGX $PHARM $ALCLS $CLLS $DBV $DBVT $ERYP $IPH $CYAD $GNFT $VLA $AB $NANO $TNG $COX $SIGHT $ALPHA $TXCL & many more

https://t.co/gaIZF10amx

[David Crow @bydavidcrow]

In the deals frenzy of 2015-16, Big Pharma payed record premiums to acquire smaller biotech companies. But did they get their money's worth? https://t.co/NrWN9T0A8f

[HealthCap @HealthCapVC]

Nordic Nanovector announces that Luigi Costa will step down as Chief Executive Officer https://t.co/0worUW6B5w